T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Roper Technologies
ROP
|
$795M |
| 2 |
Abbott
ABT
|
$750M |
| 3 |
Thermo Fisher Scientific
TMO
|
$746M |
| 4 |
Becton Dickinson
BDX
|
$730M |
| 5 |
Cigna
CI
|
$725M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.32B |
| 2 |
Martin Marietta Materials
MLM
|
$959M |
| 3 |
Linde
LIN
|
$839M |
| 4 |
AbbVie
ABBV
|
$829M |
| 5 |
Intercontinental Exchange
ICE
|
$814M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 12.47% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
601
AbbVie
ABBV
$374B
| $1.07M | ﹤0.01% |
6,000
-4,661,205
| -100% | -$829M |
|
602
Lockheed Martin
LMT
$105B
| $841K | ﹤0.01% |
1,729
+19
| +1% | +$9.24K |
|
603
Fiserv
FI
$74.3B
| $794K | ﹤0.01% |
3,862
+44
| +1% | +$9.05K |
|
604
Waste Management
WM
$90.4B
| $781K | ﹤0.01% |
3,866
+44
| +1% | +$8.89K |
|
605
Morgan Stanley
MS
$237B
| $733K | ﹤0.01% |
5,827
-47,449
| -89% | -$5.97M |
|
606
T-Mobile US
TMUS
$284B
| $719K | ﹤0.01% |
3,256
+21
| +0.6% | +$4.64K |
|
607
Stryker
SYK
$149B
| $710K | ﹤0.01% |
1,971
-9,927
| -83% | -$3.58M |
|
608
HCA Healthcare
HCA
$95.4B
| $676K | ﹤0.01% |
2,251
+25
| +1% | +$7.51K |
|
609
EOG Resources
EOG
$65.8B
| $592K | ﹤0.01% |
4,826
-357
| -7% | -$43.8K |
|
610
Zoetis
ZTS
$67.6B
| $591K | ﹤0.01% |
3,627
+358
| +11% | +$58.3K |
|
611
Mondelez International
MDLZ
$79.3B
| $573K | ﹤0.01% |
9,587
+109
| +1% | +$6.52K |
|
612
Exelon
EXC
$43.8B
| $572K | ﹤0.01% |
15,174
-6,298,087
| -100% | -$237M |
|
613
Adobe
ADBE
$148B
| $538K | ﹤0.01% |
1,208
+12
| +1% | +$5.34K |
|
614
Illinois Tool Works
ITW
$76.2B
| $531K | ﹤0.01% |
2,091
+25
| +1% | +$6.35K |
|
615
VeriSign
VRSN
$25.6B
| $505K | ﹤0.01% |
2,440
+28
| +1% | +$5.8K |
|
616
IQVIA
IQV
$31.4B
| $496K | ﹤0.01% |
2,520
+544
| +28% | +$107K |
|
617
Elevance Health
ELV
$72.4B
| $494K | ﹤0.01% |
1,338
-30,321
| -96% | -$11.2M |
|
618
Colgate-Palmolive
CL
$67.7B
| $456K | ﹤0.01% |
+5,014
| New | +$456K |
|
619
O'Reilly Automotive
ORLY
$88.1B
| $455K | ﹤0.01% |
5,745
+45
| +0.8% | +$3.56K |
|
620
Applied Materials
AMAT
$124B
| $433K | ﹤0.01% |
2,662
+30
| +1% | +$4.88K |
|
621
TE Connectivity
TEL
$60.9B
| $428K | ﹤0.01% |
2,989
+35
| +1% | +$5.01K |
|
622
Middleby
MIDD
$6.87B
| $387K | ﹤0.01% |
+2,853
| New | +$387K |
|
623
Lennar Class A
LEN
$34.7B
| $370K | ﹤0.01% |
2,798
+202
| +8% | +$26.7K |
|
624
Evergy
EVRG
$16.4B
| $346K | ﹤0.01% |
5,609
+65
| +1% | +$4.01K |
|
625
Dover
DOV
$24B
| $340K | ﹤0.01% |
1,808
-469
| -21% | -$88.2K |
|